Following evidence from the SELECT trial, the UK's medicines regulator approved Wegovy for use in patients with cardiovascular disease, allowing it to be prescribed privately
Many intrinsic and extrinsic factors, such as neurotrophic factors, transcription factors, cell cycle regulators, cell proliferation, neurogenic niche and differentiation into mature neurons, play an important role in the pathomechanism of AD
A Dual-Pathway Approach to Metabolic Therapy Tirzepatide is a synthetic peptide that activates two metabolic receptors at once: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
These traits have led to its use in many gluten-free products, including flours, breads, cereals, energy bars, and beverages